Single Doses of Antibody Drug Conjugates (ADCs) Targeted to CD117 or CD45 Have Potent in Vivo Anti-Leukemia Activity and Survival Benefit in Patient Derived AML Models

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.368

Related search